Bradford T. Whitmore, 10% Owner at Clearside Biomedical, Inc. (CLSD), bought 206,590 shares at $0.73 ($151K) on 2023-10-31, disclosed to the SEC on 2023-11-01.
Open-market purchase of $151k CLSD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 600 | $414 | 0.3% |
| 2 | $0.73 | 70,812 | $52K | 34.1% |
| 3 | $0.73 | 70,812 | $52K | 34.1% |
| 4 | $0.74 | 64,366 | $48K | 31.5% |
| Total | $0.73 avg | 206,590 | $151K | 100% |
| Filing → |
| ULBI | BUY | 2025-12-16 | $602K | — | Filing → |
| ULBI | BUY | 2025-11-21 | $268K | — | Filing → |
| ULBI | BUY | 2025-08-21 | $689K | — | Filing → |